Back to results
US 2025/0084454 A1Published application
Multiplexed immunosignal amplification using hybridization chain reaction-based method
AssigneeGenAns Biotechnology Co., Ltd
InventorsRui LIN, Minmin LUO
Life of this patent
Estimating the term…
Abstract
The invention provides a method for optimizing isHCR for multiplexed labeling, which combines binder-biomolecule interactions with hybridization Chain Reaction (HCR).
Claims6
A method for detecting multiple target biomolecules by using a kit, the kit comprising:
- (1) orthogonal binders;
- (2) orthogonal Hybridization Chain Reaction (HCR) initiators;
- and
- (3) orthogonal pairs of HCR amplifiers, wherein each of HCR initiators has a region for hybridizing with a HCR amplifier, and a region for conjugating the orthogonal binders, and the orthogonal binders target multiple target biomolecules respectively to allow HCR amplification directed to multiple target biomolecules,
- wherein the orthogonal binders are orthogonal antibodies, orthogonal single-domain antibodies (sdAbs), or fragments thereof,
- wherein the orthogonal HCR initiators are directly conjugated to the orthogonal binders using click chemistry linkers which are selected from NHS-Azide linker, NHS-DBCO linker, maleimide-azide linker, and maleimide-DBCO linker, and
- wherein the orthogonal HCR initiators are conjugated to the orthogonal binders by reacting DBCO-labeled HCR initiators with azide-activated binders, and
- wherein the HCR amplifiers or the orthogonal pairs of HCR amplifiers are internally modified with a chemical group or a fluorescent dye, and the modification with a chemical group allows initiating further rounds of amplification.
5 more elements
Dependencies are inferred from the claim text.